146 related articles for article (PubMed ID: 24222125)
41. Blockade of epidermal growth factor receptor signaling leads to inhibition of renal cell carcinoma growth in the bone of nude mice.
Weber KL; Doucet M; Price JE; Baker C; Kim SJ; Fidler IJ
Cancer Res; 2003 Jun; 63(11):2940-7. PubMed ID: 12782601
[TBL] [Abstract][Full Text] [Related]
42. Expression of neural cell adhesion molecule in renal cell carcinoma.
Cirović SL; Cegar BS; Vjestica JM; Dundjerović DM; Stojanović MM; Vuksanović AM; Mitrović DB; Lazić MD; Tulić CD; Marković-Lipkovski JZ
Acta Chir Iugosl; 2012; 59(1):39-44. PubMed ID: 22924301
[TBL] [Abstract][Full Text] [Related]
43. Possible reversibility between epithelioid and sarcomatoid types of mesothelioma is independent of ERC/mesothelin expression.
Kojima M; Kajino K; Momose S; Wali N; Hlaing MT; Han B; Yue L; Abe M; Fujii T; Ikeda K; Hino O
Respir Res; 2020 Jul; 21(1):187. PubMed ID: 32677949
[TBL] [Abstract][Full Text] [Related]
44. Cell proliferative activity and expression of cell-cell adhesion factors (E-cadherin, alpha-, beta-, and gamma-catenin, and p120) in sarcomatoid renal cell carcinoma.
Kuroiwa K; Konomoto T; Kumazawa J; Naito S; Tsuneyoshi M
J Surg Oncol; 2001 Jun; 77(2):123-31. PubMed ID: 11398166
[TBL] [Abstract][Full Text] [Related]
45. C-met inhibition blocks bone metastasis development induced by renal cancer stem cells.
D'Amico L; Belisario D; Migliardi G; Grange C; Bussolati B; D'Amelio P; Perera T; Dalmasso E; Dalle Carbonare L; Godio L; Comoglio P; Trusolino L; Ferracini R; Roato I
Oncotarget; 2016 Jul; 7(29):45525-45537. PubMed ID: 27322553
[TBL] [Abstract][Full Text] [Related]
46. Sarcomatoid renal cell carcinoma presenting in the oropharynx.
Gammon BL; Gleason BC; Thomas AB; Cibull TL
J Cutan Pathol; 2010 Dec; 37(12):1255-8. PubMed ID: 20590964
[TBL] [Abstract][Full Text] [Related]
47. Use of PAX8 and GATA3 in diagnosing sarcomatoid renal cell carcinoma and sarcomatoid urothelial carcinoma.
Chang A; Brimo F; Montgomery EA; Epstein JI
Hum Pathol; 2013 Aug; 44(8):1563-8. PubMed ID: 23453625
[TBL] [Abstract][Full Text] [Related]
48. Isolation and characterization of renal cancer stem cells from patient-derived xenografts.
Hasmim M; Bruno S; Azzi S; Gallerne C; Michel JG; Chiabotto G; Lecoz V; Romei C; Spaggiari GM; Pezzolo A; Pistoia V; Angevin E; Gad S; Ferlicot S; Messai Y; Kieda C; Clay D; Sabatini F; Escudier B; Camussi G; Eid P; Azzarone B; Chouaib S
Oncotarget; 2016 Mar; 7(13):15507-24. PubMed ID: 26551931
[TBL] [Abstract][Full Text] [Related]
49. [Pax-2 antigen expression in kidney tumours].
Vjestica JM; Marković-Lipkovski J; Tulić CD; Djokić MR; Segar BS; Cirović SL; Stojanović MM; Vuksanović AM
Acta Chir Iugosl; 2011; 58(4):15-20. PubMed ID: 22519185
[TBL] [Abstract][Full Text] [Related]
50. Utility of PAX8 and PAX2 immunohistochemistry in the identification of renal cell carcinoma in diagnostic cytology.
Knoepp SM; Kunju LP; Roh MH
Diagn Cytopathol; 2012 Aug; 40(8):667-72. PubMed ID: 22807381
[TBL] [Abstract][Full Text] [Related]
51. Co-Expression of Multiple
Li L; Li CG; Almomani SN; Hossain SM; Eccles MR
Int J Mol Sci; 2023 Jul; 24(14):. PubMed ID: 37511191
[TBL] [Abstract][Full Text] [Related]
52. [Study on morphological and immunophenotypic features of renal cell carcinoma with sarcomatoid differentiation].
Xiao L; Lu XY; Tang RY; Deng M; Zhu XZ
Zhonghua Bing Li Xue Za Zhi; 2007 Apr; 36(4):259-60. PubMed ID: 17706118
[No Abstract] [Full Text] [Related]
53. PAX2 inactivation enhances cisplatin-induced apoptosis in renal carcinoma cells.
Hueber PA; Waters P; Clark P; Eccles M; Goodyer P
Kidney Int; 2006 Apr; 69(7):1139-45. PubMed ID: 16609680
[TBL] [Abstract][Full Text] [Related]
54. Sarcomatoid renal cell carcinoma with foci of chromophobe carcinoma.
Cserni G; Kovács BR; Tarján M; Sápi Z; Domján Z; Szabó Z
Pathol Oncol Res; 2002; 8(2):142-4. PubMed ID: 12172580
[TBL] [Abstract][Full Text] [Related]
55. Sarcomatoid and Rhabdoid Renal Cell Carcinoma: Clinical, Pathologic, and Molecular Genetic Features.
Adeniran AJ; Shuch B; Humphrey PA
Am J Surg Pathol; 2024 Jul; 48(7):e65-e88. PubMed ID: 38736105
[TBL] [Abstract][Full Text] [Related]
56. A bone-seeking clone exhibits different biological properties from the ACHN parental human renal cell carcinoma in vivo and in vitro.
Wang J; Chen A; Yang C; Zeng H; Qi J; Guo FJ
Oncol Rep; 2012 Apr; 27(4):1104-10. PubMed ID: 22139406
[TBL] [Abstract][Full Text] [Related]
57. Renal carcinoma CD105-/CD44- cells display stem-like properties in vitro and form aggressive tumors in vivo.
Fiedorowicz M; Khan MI; Strzemecki D; Orzeł J; Wełniak-Kamińska M; Sobiborowicz A; Wieteska M; Rogulski Z; Cheda L; Wargocka-Matuszewska W; Kilian K; Szczylik C; Czarnecka AM
Sci Rep; 2020 Mar; 10(1):5379. PubMed ID: 32214151
[TBL] [Abstract][Full Text] [Related]
58. Expression of Pax2 in human renal tumor-derived endothelial cells sustains apoptosis resistance and angiogenesis.
Fonsato V; Buttiglieri S; Deregibus MC; Puntorieri V; Bussolati B; Camussi G
Am J Pathol; 2006 Feb; 168(2):706-13. PubMed ID: 16436683
[TBL] [Abstract][Full Text] [Related]
59. Impact of histology on the treatment outcome of metastatic or recurrent renal cell carcinoma.
Wu J; Caliendo G; Hu XP; Dutcher JP
Med Oncol; 1998 Apr; 15(1):44-9. PubMed ID: 9643530
[TBL] [Abstract][Full Text] [Related]
60. Three-dimensional (3D) culture of bone-derived human 786-O renal cell carcinoma retains relevant clinical characteristics of bone metastases.
Pan T; Fong EL; Martinez M; Harrington DA; Lin SH; Farach-Carson MC; Satcher RL
Cancer Lett; 2015 Aug; 365(1):89-95. PubMed ID: 26004343
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
